A detailed history of Marshall Wace, LLP transactions in Medtronic PLC stock. As of the latest transaction made, Marshall Wace, LLP holds 267,936 shares of MDT stock, worth $23.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
267,936
Previous 20,723 1192.94%
Holding current value
$23.6 Million
Previous $1.81 Million 1067.72%
% of portfolio
0.03%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$78.71 - $87.02 $19.5 Million - $21.5 Million
247,213 Added 1192.94%
267,936 $21.1 Million
Q1 2024

May 15, 2024

BUY
$82.84 - $88.09 $911,654 - $969,430
11,005 Added 113.24%
20,723 $1.81 Million
Q4 2023

Feb 14, 2024

SELL
$69.43 - $83.43 $84,704 - $101,784
-1,220 Reduced 11.15%
9,718 $800,000
Q3 2023

Nov 14, 2023

SELL
$78.22 - $90.4 $42.3 Million - $48.9 Million
-541,162 Reduced 98.02%
10,938 $857,000
Q2 2023

Aug 14, 2023

BUY
$79.47 - $91.38 $34.1 Million - $39.2 Million
429,502 Added 350.33%
552,100 $48.6 Million
Q1 2023

May 15, 2023

SELL
$76.72 - $87.58 $33.6 Million - $38.4 Million
-437,912 Reduced 78.13%
122,598 $9.88 Million
Q4 2022

Feb 14, 2023

SELL
$76.18 - $87.74 $91.8 Million - $106 Million
-1,205,190 Reduced 68.26%
560,510 $43.6 Million
Q3 2022

Nov 14, 2022

BUY
$80.75 - $95.31 $13.2 Million - $15.5 Million
163,062 Added 10.17%
1,765,700 $143 Million
Q2 2022

Aug 15, 2022

BUY
$87.4 - $113.09 $120 Million - $155 Million
1,372,189 Added 595.44%
1,602,638 $144 Million
Q1 2022

May 16, 2022

SELL
$100.58 - $112.38 $14.3 Million - $15.9 Million
-141,685 Reduced 38.07%
230,449 $25.6 Million
Q4 2021

Feb 14, 2022

BUY
$99.53 - $127.75 $22 Million - $28.3 Million
221,428 Added 146.93%
372,134 $38.5 Million
Q3 2021

Nov 15, 2021

BUY
$122.75 - $135.17 $8.82 Million - $9.71 Million
71,818 Added 91.04%
150,706 $18.9 Million
Q2 2021

Aug 13, 2021

SELL
$118.19 - $131.5 $691,647 - $769,538
-5,852 Reduced 6.91%
78,888 $9.79 Million
Q1 2021

May 17, 2021

SELL
$111.18 - $119.74 $21.1 Million - $22.7 Million
-189,379 Reduced 69.09%
84,740 $10 Million
Q4 2020

Feb 16, 2021

SELL
$100.57 - $117.14 $55.8 Million - $65 Million
-554,526 Reduced 66.92%
274,119 $32.1 Million
Q3 2020

Nov 16, 2020

BUY
$90.13 - $108.78 $74.7 Million - $90.1 Million
828,645 New
828,645 $86.1 Million
Q1 2020

May 15, 2020

SELL
$72.92 - $121.3 $7.46 Million - $12.4 Million
-102,255 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$104.49 - $114.54 $10.7 Million - $11.7 Million
102,255 New
102,255 $11.6 Million
Q2 2019

Aug 14, 2019

SELL
$84.15 - $99.38 $9.45 Million - $11.2 Million
-112,270 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$82.45 - $93.79 $6.21 Million - $7.07 Million
75,372 Added 204.27%
112,270 $10.2 Million
Q4 2018

Feb 14, 2019

BUY
$85.8 - $99.49 $1.2 Million - $1.39 Million
13,936 Added 60.69%
36,898 $3.36 Million
Q3 2018

Nov 14, 2018

BUY
$85.91 - $99.17 $1.97 Million - $2.28 Million
22,962 New
22,962 $2.26 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $117B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.